Alimentiv

On #ClinicalTrialsDay, we recognize the people who make clinical research possible and the importance of making it accessible to patients everywhere. 🌏 GI disease affects patients on all continents. At Alimentiv, we’re proud to be a global company with an extensive site network – we go where the disease is. Judi Hall, VP, Global Resource Management, explains that it’s the infrastructure, expertise, and collaboration across regions that make GI trials possible. Together, we’re working to expand access, accelerate discovery, and ultimately improve outcomes for patients living with GI disease around the globe. #GIIsOurWhy #CTD2026 #ResearchRising

🟣 On #WorldIBDDay, we focus on the people living with #IBD and the journeys that shape our essential work. At Alimentiv, many of us know firsthand why high-quality GI research matters. Hilary Warwick, Financial Analyst at Alimentiv, discusses her personal experience with #CrohnsDisease as part of our 𝐎𝐧𝐞 𝐏𝐮𝐫𝐩𝐨𝐬𝐞, 𝐌𝐚𝐧𝐲 𝐒𝐭𝐨𝐫𝐢𝐞𝐬 series. This purpose drives us to build specialized GI trials that make better outcomes possible. Because GI Is Our Why. #GIIsOurWhy #WorldIBDDay2026

At Alimentiv, 𝗚𝗜 𝗜𝘀 𝗢𝘂𝗿 𝗪𝗵𝘆, and this year, we brought that to life in a very personal way through a Gluten-Free Recipe Collection in recognition of 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗖𝗲𝗹𝗶𝗮𝗰 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗗𝗮𝘆. 💚 What we received went far beyond recipes. We heard stories of families adapting cherished traditions after a celiac diagnosis. Of grandparents reworking holiday baking so everyone could still take part. Of simple, reliable recipes that make daily life easier and more inclusive. These recipes reflect something bigger than ingredients. They reflect care, resilience, and connection. We’re also excited to feature our Chef’s Choice recipe: 𝗚𝗹𝘂𝘁𝗲𝗻-𝗙𝗿𝗲𝗲 𝗖𝗮𝗽𝗿𝗲𝘀𝗲 𝗤𝘂𝗶𝗰𝗵𝗲. Thank you to everyone who contributed and shared their story. You’ve helped bring our “why” to life in a way that is both meaningful and deeply human. Download the winning recipe! 👉 https://loom.ly/btiAZqE #GIIsOurWhy #ShineALightOnCeliac #Together4Coeliacs

𝗪𝗵𝘆 𝗚𝗜? Because better data leads to better outcomes — and patients deserve nothing less. For more than 30 years, Alimentiv has led the science of GI clinical trials. From global trial design and patient recruitment to imaging, histopathology, and endpoints you can trust, our purpose‑built GI infrastructure delivers the rigor, consistency, and partnership sponsors need to accelerate development with confidence. We’re proud to have supported over 70% of IBD compounds in development — and we’re just getting started. ✨ 𝗚𝗜 𝗜𝘀 𝗢𝘂𝗿 𝗪𝗵𝘆. Watch our story. #GIIsOurWhy #Alimentiv #GIResearch #ClinicalTrials #DrugDevelopment #IBD

Thank you to everyone who attended our #AI Learning Lab at #DDW2026! AI is transforming endoscopy scoring in UC, CD3+ quantification in celiac disease, and fibrosis quantification in IBD. Connect with our experts to learn more: 👉 https://loom.ly/WAJ_pnk AcelaBio | Dova Health Intelligence | #PathwaysGI | PharmaNest #Endoscopy #Pathology #UlcerativeColitis #CeliacDisease #Fibrosis

For over 30 years, Alimentiv has led the science of gastroenterology clinical research — 𝘀𝘂𝗽𝗽𝗼𝗿𝘁𝗶𝗻𝗴 >𝟳𝟬% 𝗼𝗳 𝗜𝗕𝗗 𝗰𝗼𝗺𝗽𝗼𝘂𝗻𝗱𝘀 in development, and building a global network of 𝟱,𝟬𝟬𝟬+ 𝘀𝗶𝘁𝗲𝘀 𝗮𝗰𝗿𝗼𝘀𝘀 𝟲𝟬+ 𝗰𝗼𝘂𝗻𝘁𝗿𝗶𝗲𝘀. We don’t just run trials, we advance the science behind them. 𝗢𝘂𝗿 𝘂𝗻𝗺𝗮𝘁𝗰𝗵𝗲𝗱 #𝗚𝗜 𝘀𝗽𝗲𝗰𝗶𝗮𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘀 𝘁𝗵𝗲 𝗳𝗼𝗰𝘂𝘀 𝗮𝗻𝗱 𝗱𝗮𝘁𝗮 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝗱 𝗳𝗼𝗿 𝗲𝘅𝗰𝗲𝗽𝘁𝗶𝗼𝗻𝗮𝗹 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀. See how we advance GI science: https://loom.ly/nags0iY #GIIsOurWhy #ClinicalTrials #ClinicalResearch #Alimentiv

Thank you #DDW2026 for an incredible meeting! Each year, we’re inspired by work going into treating GI diseases, and the scientific and technological innovations that will help us get there. Thank you to everyone who visited our booth, attended our AI learning sessions and poster sessions, and met with us to talk clinical trials. Couldn’t connect in Chicago? Meet with an expert anytime: https://loom.ly/o5g7s50 #ClinicalResearch #GIdisease #GIIsOurWhy #Alimentiv

𝗪𝗵𝗲𝗻 𝗶𝘁 𝗰𝗼𝗺𝗲𝘀 𝘁𝗼 𝗚𝗜 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵, 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲 𝗺𝗮𝘁𝘁𝗲𝗿𝘀. We’re a trusted scientific partner for sponsors advancing therapies for ulcerative colitis, Crohn’s disease, and related indications. This level of involvement reflects decades of GI-focused scientific leadership that help us navigate complexity, accelerate timelines, and generate that data sponsors and regulators trust. Discover how our GI expertise can strengthen your program: https://loom.ly/ZHLio08 #GIIsOurWhy #IBDResearch #ClinicalTrials #Gastroenterology #CROLeadership

A gluten-free diet has long been the only option for people with celiac disease — but it isn’t enough. The need for evidence-based therapies is growing. At Alimentiv, we bring deep GI expertise, validated outcomes measures, centralized imaging and proven trial design to advance new therapeutic options that can change lives. Through our global research network and operational excellence, we’re enabling sponsors to run trials smarter and move the field toward more meaningful outcomes for patients with celiac disease. Explore our celiac focus: https://loom.ly/vYXau5c #CeliacDisease #ClinicalTrials #GIResearch #BeyondTheDiet #Alimentiv

DDW marked the second conference where we brought GI Is Our Why to life — this time, for the entire GI community. This year was especially meaningful as we unveiled Alimentiv’s refreshed brand and formally introduced our brand story: 𝗚𝗜 𝗜𝘀 𝗢𝘂𝗿 𝗪𝗵𝘆 — a reflection of our deep commitment to advancing GI science across the full spectrum of the gastroenterology field. Thank you to everyone who stopped by our booth, joined our sessions, and shared this milestone with us. Your engagement and collaboration continue to fuel innovation in GI research and reinforce the purpose that drives everything we do. Missed us at DDW? No problem — you can still connect with our GI experts: https://loom.ly/2GoiBH8 We'll see you next year at #DDW2027 in Washington, D.C.! 🏛️ #GIresearch #DDW2026 #Alimentiv #GIIsOurWhy